학술논문

Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)
Document Type
Article
Source
In ESMO Open August 2021 6(4)
Subject
Language
ISSN
2059-7029